Pancreatic endocrine function in patients treated with ciclosporine, azathioprine and prednisone after kidney transplantation.
Zukowska-Szczechowska
E
E
Grzeszczak
W
W
Kokot
F
F
Nieszporek
T
T
Kuśmierski
S
S
Kurzbauer
R
R
Szkodny
A
A
D000328:Adult; D001379:Azathioprine / Q000009:adverse effects* / Q000627:therapeutic use; D003524:Cyclosporins / Q000009:adverse effects* / Q000627:therapeutic use; D005260:Female; D005934:Glucagon / Q000097:blood; D006801:Humans; D007165:Immunosuppression Therapy; D007328:Insulin / Q000097:blood; D007676:Kidney Failure, Chronic / Q000503:physiopathology / Q000601:surgery; D016030:Kidney Transplantation; D007700:Kinetics; D008297:Male; D008875:Middle Aged; D010179:Pancreas / Q000503:physiopathology*; D010191:Pancreatic Polypeptide / Q000097:blood; D011241:Prednisone / Q000009:adverse effects* / Q000627:therapeutic use
D003524:Cyclosporins; D007328:Insulin; D010191:Pancreatic Polypeptide; D005934:Glucagon; D001379:Azathioprine; D011241:Prednisone